Crinetics Pharmaceuticals Income After Taxes 2017-2024 | CRNX

Crinetics Pharmaceuticals income after taxes for the twelve months ending September 30, 2024 was $-0.273B, a 37.7% increase year-over-year.

  • Crinetics Pharmaceuticals annual income after taxes for 2023 was $-0.209B, a 28.5% increase from 2022.
  • Crinetics Pharmaceuticals annual income after taxes for 2022 was $-0.163B, a 51.34% increase from 2021.
  • Crinetics Pharmaceuticals annual income after taxes for 2021 was $-0.108B, a 45.83% increase from 2020.

Crinetics Pharmaceuticals Income After Taxes 2017-2024 | CRNX

  • Crinetics Pharmaceuticals annual income after taxes for 2023 was $-0.209B, a 28.5% increase from 2022.
  • Crinetics Pharmaceuticals annual income after taxes for 2022 was $-0.163B, a 51.34% increase from 2021.
  • Crinetics Pharmaceuticals annual income after taxes for 2021 was $-0.108B, a 45.83% increase from 2020.